Pharsight Welcomes Newest Japanese PKS, AutoPilo...(norpresident chief executive officer and...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
Date:2/26/2008
nor, president, chief executive officer and chairman of Pharsight. "The flexibility of PKS and AutoPilot allows clients to configure their solution to meet the needs of their PK analysis workflow and to efficiently produce the type of reports mandated by regulatory authorities. The potential productivity gains from automating this work are large, with the ability to reduce the labor required to generate these outputs by 80% in some cases. We believe clients will continue to invest in our market-leading software products because they offer a tangible return on investment as well as a proven pathway to more efficient drug development."
About PKS
The Pharsight Knowledgebase Server (PKS) is a high productivity, regulatory-compliant enterprise data management system. PKS is now installed in over 20 major pharmaceutical and biotechnology companies and also at FDA in connection with an extensive Pharsight FDA Cooperative Research and Development Agreement. PKS enables pharmaceutical and biopharmaceutical companies to better manage and control preclinical and clinical kinetic and dynamic data and analyses. Companies use PKS to build pharmacokinetic and pharmacodynamic (PK/PD) data management architecture compliant with FDA regulation 21 CFR Part 11, which has set new standards for computer system validation and usage. The PKS software is designed to complement Pharsight's modeling and simulation technology for computer-based drug disease modeling and clinical trial simulation. PKS supports analysis in leading tools such as WinNonlin(R), NONMEM(R), and SAS(R) as well as connectivity to LIMS such as Watson LIMS.
About WinNonlin AutoPilot
WinNonlin AutoPilot orchestrates PK analyses by selecting input data
from a user's local file system or PKS, and then directs WinNonlin(R) to
perform analyses and produce report quality tables, figures, and text
output (e.g., in Microsoft (R) Excel, SigmaPlot(R), and Microsoft(R) Word)
for regulatory submissions an
'/>"/>
| SOURCE Pharsight Corporation Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
2. Pharsight Achieves $7.4 Million in Quarterly Revenue
3. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
4. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
5. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
6. Pharsight Announces 1-For-3 Reverse Stock Split
7. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
8. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
9. Pharsight Hosts Fourth Annual PKS User Group Meeting
10. Pharsight Expands Strategic Consulting Services Team
11. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
Post Your Comments:
Breaking Biology Technology:Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4New antioxidant compounds have been identified in foods such as olive oil, honey and nuts 2Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 2Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 3Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 4PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision 2
[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics[0] New antioxidant compounds have been identified in foods such as olive oil, honey and nuts[0] Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit[0] PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
Other Biology Technology:YM Biosciences announces adoption of renewed Shareholders' Rights Plan 2YM Biosciences announces adoption of renewed Shareholders' Rights Plan 3Aida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer 2Aida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer 3Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors 2Indevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors 3
YM Biosciences announces adoption of renewed Shareholders' Rights PlanAida's Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney CancerIndevus Pharmaceuticals Announces Retirement of David B. Sharrock From Its Board of Directors
Breaking Biology News(10 mins):77 percent of European pigs are castrated without anesthetic 2University of the Basque Country research on plankton at Urdaibai 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2Easter Island Drug Adds Years to Mice 51114 1Easter Island Drug Adds Years to Mice 51114 2B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 1B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 2B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 3B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 4B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 5B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 6Most neuropsychological tests dont tell Alzheimers disease from vascular dementia 51105 1Most neuropsychological tests dont tell Alzheimers disease from vascular dementia 51105 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |